Latest news with #MariMed
Yahoo
29-05-2025
- Business
- Yahoo
MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose
All-Natural Line of Wellness Products Designed to Support Overall Well-Being Now Available in Massachusetts NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ('MariMed') (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature's Heritage™, continued to drive innovation with the launch of , a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benefits of functional mushrooms in a convenient pill form. MycroDose by Nature's Heritage delivers four targeted, plant-based solutions designed to enhance mental clarity, promote relaxation, improve focus, and support overall well-being in four distinct formulations. They are available now in Massachusetts at MariMed's own Panacea Wellness stores and other select dispensaries. The new line was developed to provide new and existing consumers with a unique, balanced, and controlled experience. Each of the four MycroDose by Nature's Heritage products are uniquely crafted with a specific blend of all natural vegan ingredients to cater to a variety of needs. The complete line-up includes: Chill – Designed for relaxation and stress relief, Chill features THC, CBD, and q, blended with the functional mushrooms Organic Cordyceps and Organic Lion's Mane, and the root plant, Ashwagandha. G'Night – A formulation aimed at improved sleep and deep relaxation, G'Night combines THC, CBN, CBD with functional mushrooms Organic Reishi and Organic Lion's Mane, as well as Chamomile and Magnesium. Remedy – A product focused on reducing inflammation while providing a calm state of mind, Remedy features THC, CBD, and CBC, blended with the functional mushroom Oyster, Ginger root, Turmeric, and Piperine. Spark – An energizing blend designed to improve energy, focus, and mental clarity, Spark is formulated with Shiitake mushrooms, Organic Lion's Mane, Ginseng, THCV, and THC. "Nature's Heritage is proud to introduce a groundbreaking new line of products that harnesses the synergy between high-quality cannabis, functional mushrooms, and herbs to deliver a truly elevated experience," said Tami Kirlis, MariMed Brand Director for Nature's Heritage. "Our team meticulously researched and developed innovative formulas that enhance well-being, mental clarity, and relaxation in a way that's truly distinct. Nature's Heritage prioritizes natural ingredients to enhance health and well-being, and MycroDose by Nature's Heritage delivers on that mission.' To learn more about MycroDose by Nature's Heritage and where to purchase the line in Massachusetts, visit About MariMedMariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit Media Contact:Zach GalassoDPA Communications Email: zach@ (978) 604-5423 Company Contact:Howard SchacterChief Communications Officer Email: hschacter@ (781) 277-0007
Yahoo
09-05-2025
- Business
- Yahoo
MariMed Inc (MRMD) Q1 2025 Earnings Call Highlights: Strategic Expansion Amidst Market Challenges
Release Date: May 08, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. MariMed Inc (MRMD) reported a 16% year-over-year increase in wholesale gross revenue, indicating strong market penetration. The company successfully expanded its brand presence, selling products into 70 new storefronts during the quarter. MariMed Inc (MRMD) is actively pursuing M&A opportunities and licensing deals to enter new high-growth markets, which could drive future growth. The company is launching innovative new products, such as the Microdose by Nature's Heritage, which taps into the growing trend of functional mushrooms. MariMed Inc (MRMD) maintains a strong balance sheet with $7.2 million in cash and cash equivalents, supporting its strategic initiatives. Overall revenue for the quarter was flat year-over-year, reflecting challenges in the retail segment. The company reported a net loss of $5.4 million for the quarter, an increase from the previous year's loss of $1.3 million. Gross margins declined to 41.3% from 43.8% in the same period last year, primarily due to price compression and increased costs. Retail revenue decreased by 7% year-over-year, impacted by market challenges and economic uncertainty. MariMed Inc (MRMD) faces challenges in the Missouri market due to strong local operator networks and reciprocity issues. Warning! GuruFocus has detected 8 Warning Signs with MRMD. Q: Can you clarify whether the expected revenue increase in the second quarter is on a quarter-over-quarter or year-over-year basis? A: Hi Andrew, it's Mario, the Chief Financial Officer. The expected revenue increase is on a quarter-over-quarter basis. Q: What are the latest expectations for adult-use sales in Delaware, and when might we expect to see that launch? A: Morning, Andrew. Delaware has finally appointed a lead for the cannabis program, and we anticipate that the first recreational store could open in 60 to 120 days. Q: Regarding the bad debt expense in the quarter, is this a one-time item, or could it recur later in the year? A: Hi Andrew, it's Mario. Yes, this is a one-time item and does not relate to our trade receivables. It pertains to a receivable from a vendor, and we are pursuing all actions to collect the funds. Q: Can you provide more details on the new hemp products and the distribution strategy for Microdose? A: Morning, Pablo. We are exploring various options for hemp products, including beverages and other lines, but no final decision has been made. As for Microdose, it will be widely distributed across all our states, not just in dispensaries. Q: How do you view the opportunity for licensing your brands, especially in fast-growing markets like New York? A: We are open to licensing opportunities in New York and other states, but it's crucial to find the right partner who aligns with our standards and dedication. Q: Can you provide an update on the second Maryland store and the potential upside from Delaware's market? A: Our Upper Marlboro store in Maryland is performing well. In Delaware, while there are currently only seven stores, new licenses have been issued, and we are ready to expand our wholesale business as soon as the market opens. Q: Missouri seems to be more challenging than expected. Can you provide more details on the situation there? A: Missouri has a strong network of localized operators, making market entry challenging. However, we are confident that our strong brands will eventually gain more traction in the market. Q: Marketing and promotion spending was down significantly year-over-year. What is behind this decline? A: We are being more strategic with our spending, focusing on localized marketing rather than broad programmatic marketing, which accounts for the decrease. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
08-04-2025
- Business
- Yahoo
MariMed Announces First Quarter 2025 Earnings Date
NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ('MariMed' or 'Company') (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report first quarter 2025 financial results on May 7, 2025 after the markets close. Management will host a conference call on May 8, 2025 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed's Investor Relations website at MariMed Q125 Earnings Webcast. A playback of the call will also be made available on MariMed's Investor Relations website. About MariMedMariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, InHouse™, Nature's Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit Company Contact:Howard SchacterChief Communications Officer Email: hschacter@ (781) 277-0007Sign in to access your portfolio
Globe and Mail
07-04-2025
- Business
- Globe and Mail
MariMed Promotes Ryan Crandall to Chief Commercial Officer
NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ('MariMed' or 'Company') (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company's commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed's Chief Revenue Officer since July 2022, and prior was the Company's Chief Products Officer and SVP, Sales for four years. Mr. Crandall will continue to report to MariMed CEO Jon Levine. 'Ryan has been a driving force behind creating our innovative and trusted portfolio of brands and establishing them as top sellers in our core markets,' said Mr. Levine. 'He has also guided our efforts to deliver an exceptional customer experience at our retail locations. His promotion to Chief Commercial Officer is well-deserved and I look forward to his continued contributions to value generation for our customers and shareholders.' Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty's Eddies™, a brand of all-natural, cannabis-infused chews that MariMed acquired prior to his joining the company in 2018. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2. 'I am honored and excited to step into the role of Chief Commercial Officer at MariMed,' said Mr. Crandall. 'Being a part of this great company, with its award-winning brands, dedication to strategic growth initiatives, and commitment to its mission of improving lives, has been a fantastic journey. I'm eager to deepen my collaboration with our talented team, building on our collective success to strengthen MariMed's position as a leading cannabis products company.' About MariMed MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, InHouse™, Nature's Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit
Yahoo
07-04-2025
- Business
- Yahoo
MariMed Promotes Ryan Crandall to Chief Commercial Officer
NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ('MariMed' or 'Company') (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company's commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed's Chief Revenue Officer since July 2022, and prior was the Company's Chief Products Officer and SVP, Sales for four years. Mr. Crandall will continue to report to MariMed CEO Jon Levine. 'Ryan has been a driving force behind creating our innovative and trusted portfolio of brands and establishing them as top sellers in our core markets,' said Mr. Levine. 'He has also guided our efforts to deliver an exceptional customer experience at our retail locations. His promotion to Chief Commercial Officer is well-deserved and I look forward to his continued contributions to value generation for our customers and shareholders.' Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty's Eddies™, a brand of all-natural, cannabis-infused chews that MariMed acquired prior to his joining the company in 2018. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2. 'I am honored and excited to step into the role of Chief Commercial Officer at MariMed,' said Mr. Crandall. 'Being a part of this great company, with its award-winning brands, dedication to strategic growth initiatives, and commitment to its mission of improving lives, has been a fantastic journey. I'm eager to deepen my collaboration with our talented team, building on our collective success to strengthen MariMed's position as a leading cannabis products company.' About MariMedMariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, InHouse™, Nature's Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit Company Contact:Howard SchacterChief Communications Officer Email: hschacter@ (781) 277-0007
